Accessibility Menu
 
NeuroPace logo

NeuroPace

(NASDAQ) NPCE

Current Price$15.99
Market Cap$536.76M
Since IPO (2021)-37%
5 Year-24%
1 Year+22%
1 Month+6%

NeuroPace Financials at a Glance

Market Cap

$536.76M

Revenue (TTM)

$99.53M

Net Income (TTM)

$14.88M

EPS (TTM)

$-0.65

P/E Ratio

-24.36

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Price

$15.99

Volume

437

Open

$16.08

Previous Close

$15.81

Daily Range

$15.73 - $16.38

52-Week Range

$7.56 - $19.60

NPCE: Motley Fool Moneyball Superscore

70

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NeuroPace

Industry

Healthcare Equipment and Supplies

Employees

209

CEO

Joel D. Becker, MBA

Headquarters

Mountain View, CA 94043, US

NPCE Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-17%

Net Income Margin

-15%

Return on Equity

-111%

Return on Capital

-20%

Return on Assets

-15%

Earnings Yield

-4.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$536.76M

Shares Outstanding

33.95M

Volume

437

Avg. Volume

214.22K

Financials (TTM)

Gross Profit

$77.22M

Operating Income

$16.34M

EBITDA

$14.39M

Operating Cash Flow

$11.01M

Capital Expenditure

$332.00K

Free Cash Flow

$11.34M

Cash & ST Invst.

$61.06M

Total Debt

$70.84M

NeuroPace Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$22.07M

-2.0%

Gross Profit

$18.05M

+4.1%

Gross Margin

81.78%

N/A

Market Cap

$536.76M

N/A

Market Cap/Employee

$2.92M

N/A

Employees

184

N/A

Net Income

$0.00

+100.0%

EBITDA

$5.57M

-18.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$16.48M

-139.2%

Accounts Receivable

$14.79M

-4.2%

Inventory

$16.69M

+22.9%

Long Term Debt

$68.28M

-4.1%

Short Term Debt

$2.19M

+13.7%

Return on Assets

-15.04%

N/A

Return on Invested Capital

-20.26%

N/A

Free Cash Flow

$5.90M

+21.5%

Operating Cash Flow

$5.90M

+21.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CERSCerus Corporation
$2.66+2.46%
BWAYBrainsWay Ltd.
$16.61+1.81%
DCTHDelcath Systems, Inc.
$11.61-0.26%
MASS908 Devices Inc.
$7.76+2.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
FFord Motor Company
$14.52+0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$16.68-0.01%
EOSEEos Energy Enterprises
$7.51-0.09%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.01%

Questions About NPCE

What is the current price of NeuroPace?

NeuroPace is trading at $15.99 per share.

What is the 52-week range for NeuroPace?

Over the past 52 weeks, NeuroPace has traded between $7.56 and $19.60.

How much debt does NeuroPace have?

As of the most recent reporting period, NeuroPace reported total debt of $70.46M.

How much cash does NeuroPace have on hand?

NeuroPace reported $14.78M in cash and cash equivalents in its most recent financial results.

What is NeuroPace’s dividend yield?

NeuroPace does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.